leadf
logo-loader
viewAlliance Pharma PLC

Alliance Pharma delivers strong set of prelims

In common a growing band of businesses it has decided to pass on the dividend in order to conserve cash

Alliance Pharma PLC -

Alliance Pharma PLC (LON:APH) said it is focused on delivering yet further growth from its “resilient” business as it unveiled a strong set of 2019 results.

See-through revenues for the 12 months ended December 31 were up 16% to £144.3mln, which translated to underlying earnings (EBITDA) of £39.4mln, up 22%.

The company’s star brands performed well, led by its Kelo-cote scar treatment. The figures also included a first-time contribution from Nizoral, the medicated shampoo acquired from Johnson & Johnson.

Forgetting the impact of Alliance’s recent purchases, organic top-line growth was a more than creditable 10%.

Cash generation was strong, meaning the company’s net debt fell to £59.2mln from £85.8mln a year earlier, which meant Alliance’s leverage was 1.48-times earnings at the year-end, down from 2.33-times.

There was a sting in the tail for investors, though probably not totally unexpected, as Alliance decided to pass on the final dividend to conserve cash through the coronavirus crisis. It said it will reassess its position later in the year, potentially offering an interim payout.

“We will provide further updates at our AGM in May, in our first-half trading update in July and at other times as appropriate,” said chief executive Peter Butterfield in the statement.

"Notwithstanding the current uncertainty created by the coronavirus, our underlying business remains resilient, with strong financials, good liquidity and covenant headroom, and we look forward to continuing our path of growth in the years ahead."

Quick facts: Alliance Pharma PLC

Price: 73 GBX

AIM:APH
Market: AIM
Market Cap: £387.8 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Alliance Pharma PLC named herein, including the promotion by the Company of Alliance Pharma PLC in any Content on the Site, the Company...

FOR OUR FULL DISCLAIMER CLICK HERE

Market report: FTSE fights back after bruising start to week

The FTSE is fighting back after enduring the worst sell-off since June on Monday.  UK Prime Minister Boris Johnson will address the nation today about more possible lockdowns after announcing pubs, bars, restaurants and other hospitality venues in England must close by...

21 hours, 7 minutes ago

2 min read